Calamos Advisors
IRMD icon

Calamos Advisors’s iRadimed IRMD Stock Holding History

Calamos Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$829K Buy
8,671
+125
+1% +$11.4K ﹤0.01% 779
2026
Q1 		$823K Sell
8,546
-2,242
-21% -$224K ﹤0.01% 817
2025
Q4 		$1.05M Sell
10,788
-668
-6% -$57.3K ﹤0.01% 686
2025
Q3 		$815K Buy
11,456
+2,589
+29% +$173K ﹤0.01% 727
2025
Q2 		$530K Buy
8,867
+4,389
+98% +$241K ﹤0.01% 742
2025
Q1 		$235K Sell
4,478
-118
-3% -$6.63K ﹤0.01% 790
2024
Q4 		$253K Sell
4,596
-435
-9% -$22.9K ﹤0.01% 786
2024
Q3 		$253K Buy
+5,031
New +$232K ﹤0.01% 774
2024
Q2 		– Sell
-5,073
Closed -$223K – 973
2024
Q1 		$223K Sell
5,073
-30,129
-86% -$1.33M ﹤0.01% 763
2023
Q4 		$1.67M Sell
35,202
-735
-2% -$30.9K 0.01% 619
2023
Q3 		$1.59M Buy
35,937
+3,000
+9% +$139K 0.01% 637
2023
Q2 		$1.57M Buy
32,937
+1,728
+6% +$77.9K 0.01% 672
2023
Q1 		$1.23M Buy
31,209
+18,552
+147% +$674K 0.01% 782
2022
Q4 		$358K Sell
12,657
-60,105
-83% -$1.72M ﹤0.01% 921
2022
Q3 		$2.19M Sell
72,762
-7,705
-10% -$268K 0.01% 861
2022
Q2 		$2.73M Sell
80,467
-7,099
-8% -$254K 0.01% 864
2022
Q1 		$3.93M Buy
87,566
+17,822
+26% +$824K 0.01% 785
2021
Q4 		$3.22M Buy
+69,744
New +$2.81M 0.01% 802
2019
Q1 		– Sell
-11,740
Closed -$287K – 678
2018
Q4 		$287K Hold
11,740
– – ﹤0.01% 625
2018
Q3 		$436K Buy
+11,740
New +$317K ﹤0.01% 599

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Calamos Advisors's IRMD Position: Q2 2026 in Review

Calamos Advisors increased its iRadimed (IRMD) stake by 1.5% in Q2 2026, buying an estimated $11.4K and bringing the position to 8,671 shares worth $829K. The position accounts for ﹤0.01% of the portfolio, ranked #779.

Calamos Advisors first reported a position in IRMD in Q3 2018 and has held it in 20 quarters since. The position peaked at $3.93M in Q1 2022. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Calamos Advisors held 8,671 shares of iRadimed worth $829K as of Q2 2026.
  • Calamos Advisors bought 125 iRadimed shares in Q2 2026, an estimated $11.4K.
  • iRadimed made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #779 holding.
  • Calamos Advisors first reported a position in iRadimed in Q3 2018 and has held it in 20 quarters since.
  • Calamos Advisors's iRadimed position peaked at $3.93M in Q1 2022.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.